Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

McGill University

$147,790.00

Nanoconfinement based single-cell cytogenetic platform for pre-/post-implantation genetic diagnosis

FY 2014-15

Summary
Chromosomal analysis is routinely performed in Canada when there is an elevated risk of chromosomal anomalies (e.g. inthe prenatal period due to maternal age, family history of a chromosomal rearrangement). In particular, pre-implantationgenetic diagnosis (PGD) is performed on 8-cell stage embryos as part of in vitro fertilization (IVF) to ensure embryo viabilityand fetal health: roughly 7000 women undergo IVF each year in Canada, a number that is growing due to increasingmaternal age and the legally mandated provision of PGD through public health insurance. PGD must necessarily beperformed on single cells. Current methods (ex. fluorescence in situ hybridization (FISH) can screen only for limited and predeterminednumber of genetic defects. Alternatives to FISH, such as arraycomparative genomic hybridization (array-CGH), require single-cell amplification and cannot detect abnormalities such astriploidy and balanced translocations. There is a need for a single-cell cytogenetic diagnostic tool that is (a) high-throughputand (b) can yield a comprehensive high resolution analysis of single-cells without marker preselection. We propose todevelop lab-on-a-chip instrumentation for the direct optical mapping of entire genomes extracted from single-cells withapplication to prenatal genetic analysis and PGD. The technology approach will be based on using a special instrument thatcan actively impose confinement in an experiment by deforming a coverslip with a ""lens-pusher."" The instrument has thespecial property that it can shift between low and high confinement states, transforming a microfluidic device suitable forsample preparation steps into a nanofluidic device suitable for molecular analysis via DNA extension in nanofabricatedgroove structures defined on the coverslip.
Program
Collaborative Health Research Projects
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
446656-2013
Name nom
Reisner, Walter
Department département
Physics
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
147790
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
Nanoconfinement based single-cell cytogenetic platform for pre-/post-implantation genetic diagnosis
Keyword
NSERC
Application summary
Chromosomal analysis is routinely performed in Canada when there is an elevated risk of chromosomal anomalies (e.g. inthe prenatal period due to maternal age, family history of a chromosomal rearrangement). In particular, pre-implantationgenetic diagnosis (PGD) is performed on 8-cell stage embryos as part of in vitro fertilization (IVF) to ensure embryo viabilityand fetal health: roughly 7000 women undergo IVF each year in Canada, a number that is growing due to increasingmaternal age and the legally mandated provision of PGD through public health insurance. PGD must necessarily beperformed on single cells. Current methods (ex. fluorescence in situ hybridization (FISH) can screen only for limited and predeterminednumber of genetic defects. Alternatives to FISH, such as arraycomparative genomic hybridization (array-CGH), require single-cell amplification and cannot detect abnormalities such astriploidy and balanced translocations. There is a need for a single-cell cytogenetic diagnostic tool that is (a) high-throughputand (b) can yield a comprehensive high resolution analysis of single-cells without marker preselection. We propose todevelop lab-on-a-chip instrumentation for the direct optical mapping of entire genomes extracted from single-cells withapplication to prenatal genetic analysis and PGD. The technology approach will be based on using a special instrument thatcan actively impose confinement in an experiment by deforming a coverslip with a ""lens-pusher."" The instrument has thespecial property that it can shift between low and high confinement states, transforming a microfluidic device suitable forsample preparation steps into a nanofluidic device suitable for molecular analysis via DNA extension in nanofabricatedgroove structures defined on the coverslip.
McGill University - $147,790 Grant (2014-15) | Canada Spends